Ignite Creation Date:
2024-05-06 @ 5:16 PM
Last Modification Date:
2024-10-26 @ 2:25 PM
Study NCT ID:
NCT05252390
Status:
RECRUITING
Last Update Posted:
2024-05-29
First Post:
2022-01-28
Brief Title:
NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors
Sponsor:
Nuvation Bio Inc
Organization:
Nuvation Bio Inc
Organization Data
Organization:
Nuvation Bio Inc
Class:
INDUSTRY
Study ID:
NUV-868-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Nuvation Bio Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None